Sentinel node detection with imaging probe

被引:15
作者
Schillaci, O
D'Errico, G
Scafè, R
Soluri, A
Burgio, N
Santagata, A
Spanu, A
Mangano, AM
David, V
Schiaratura, A
Scopinaro, F
机构
[1] Univ Roma Tor Vergata, Rome, Italy
[2] Univ Cattolica Sacro Cuore, Rome, Italy
[3] ENEA, CR Casaccia, Rome, Italy
[4] CNR, Inst Biomed Technol, Rome, Italy
[5] Univ Sassari, Div Nucl Med, I-07100 Sassari, Italy
[6] Univ Roma La Sapienza, Dept Expt Med & Pathol, Rome, Italy
[7] Capodarco Elettron, Paliano, FR, Italy
关键词
breast cancer; high-resolution; lymphoscintigraphy; node biopsy position-sensitive photomultiplier tubes; scintigraphy;
D O I
10.1177/030089160208800334
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
A one-square-inch-field-of-view mini gamma camera, whose first prototype was built by us in 1998 and given the name imaging probe (IP), was initially employed in sentinel lymph node (SLN) detection. This is probably the best way of learning how to use it. In the present work IP was used for SLN localization by a medical team that, after having been trained by the group of nuclear physicians of "La Sapienza" University who designed and first used the detector, used IP at their own hospital to 1) acquire experience for future use during surgery (a cooperative project on IP-radioguided orthopedic surgery is ongoing) and 2) start multicenter trials with IP The SLN was identified and localized with IP and a non-imaging probe, Neoprobe 2000, in six patients with breast cancer who underwent lymphoscintigraphy for SLN biopsy. The operators who used Neoprobe and IP were blinded to each other's findings and to the results obtained with the large-field-of-view Anger camera that was used for lymphoscintigraphy. The Anger camera, IP and Neoprobe detected seven SLNs in six patients. The mean detection time was 2 mins 6 s (standard deviation (SD) 26 s) with IP, and 2 mins 18 s (SD 47 s) with Neoprobe 2000. The SLN that was most difficult to find was detected in 2 mins 56 s with IP and 3 mins 45 s with Neoprobe. The operators' subjective impression of having detected the SLN was "absolutely sure" for 7/7 nodes with IP and "absolutely sure" for 5/7 nodes with Neoprobe.
引用
收藏
页码:S32 / S35
页数:4
相关论文
共 14 条
[1]
BOLOGNESE A, 1998, RADIONUCLIDES ONCOLO, P33
[2]
DeVincentis G, 1997, ANTICANCER RES, V17, P1627
[3]
A study of sentinel node biopsy in T1 breast cancer treatment:: Experience of 48 cases [J].
Mechella, M ;
De Cesare, A ;
Di Luzio, E ;
Di Paolo, M ;
Bolognese, A ;
Scopinaro, F .
TUMORI, 2000, 86 (04) :320-321
[4]
Lymphatic mapping and sentinel lymph node biopsy in breast cancer [J].
Nieweg, OE ;
Jansen, L ;
Olmos, RAV ;
Rutgers, EJT ;
Peterse, JL ;
Hoefnagel, KA ;
Kroon, BBR .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (04) :S11-S16
[5]
Schillaci O, 1999, NEW ENGL J MED, V340, P317
[6]
Scopinaro F, 1999, EUR J NUCL MED, V26, P996
[7]
High-resolution scintimammography improves the accuracy of technetium-99m methoxyisobutylisonitrile scintimammography: use of a new dedicated gamma camera [J].
Scopinaro, F ;
Pani, R ;
De Vincentis, G ;
Soluri, A ;
Pellegrini, R ;
Porfiri, LM .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (10) :1279-1288
[8]
Detection of sentinel node in breast cancer:: Pilot study with the imaging probe [J].
Scopinaro, F ;
Pani, R ;
Soluri, A ;
Pellegrini, R ;
Scafè, R ;
De Vincentis, G ;
Capoccetti, F ;
David, V ;
Chiarini, S ;
Stella, S .
TUMORI, 2000, 86 (04) :329-331
[9]
SCOPINARO F, 1999, RADIONUCLIDES LYMPH, P60
[10]
SCOPINARO F, 1999, NUCL MED COMMUN, V20, P681